市场调查报告书
商品编码
1516492
2024-2028年全球生物电子製药市场Global Electroceutical Bioelectric Medicine Market 2024-2028 |
预计2023-2028年生物电医学市场将成长77.7469亿美元,预测期内复合年增长率为6.09%。
该报告包括对生物电医学市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。神经系统疾病盛行率的增加、心血管疾病的增加、FDA 对生物电药物的核准增加等正在推动市场的发展。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 5.65% |
复合年增长率 | 6.09% |
增量 | 777,469 万美元 |
研究指出,与神经系统疾病相关的扩大研究是推动未来几年生物电子医学市场成长的关键因素之一。报告也指出,生物电製药厂商加强研发力度以及厂商之间战略联盟的增加将带来强劲的市场需求。
The electroceutical bioelectric medicine market is forecasted to grow by USD 7774.69 mn during 2023-2028, accelerating AT a CAGR of 6.09% during the forecast period. The report on the electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of neurological disorders, increasing cardiovascular disorders, and increasing fda approval for electroceutical bioelectric medicine.
Technavio's electroceutical bioelectric medicine market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.65% |
CAGR | 6.09% |
Incremental Value | $7774.69mn |
By Type
By Application
By Geography
This study identifies the growing research related to neurological diseases as one of the prime reasons driving the electroceutical bioelectric medicine market growth during the next few years. Also, strengthening R and D on electroceutical bioelectric medicine by vendors and increasing strategic alliances between vendors will lead to sizable demand in the market.
The report on the electroceutical bioelectric medicine market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroceutical bioelectric medicine market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Bayer AG, Boston Scientific Corporation, Cochlear Ltd., Demant AS, electroCore Inc., EndoStim Inc, LivaNova PLC, MED EL Elektromedizinische Gerate GmbH, Medtronic, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Patricia Industries, Sonova Holding AG, Soterix Medical Inc., Synapse Biomedical Inc., and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.. Also, the electroceutical bioelectric medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: